<< Previous article
Introduction to Vali...
Next article > >
Low Endotoxin Recove...

4th Annual Microbiome Movement, Drug Development, Europe

Microbiome Movement - Drug Development Summit 2020

: 4 Feb 2020 - 6 Feb 2020

: London, United Kingdom

Sector: Pharmaceutical

Type: Conference


As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

 

Part of the foremost conference series for microbiome researchers in industry, the 4th Microbiome Movement – Drug Development Europe 2020 returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.

 

Find out more

Venue

London
United Kingdom


Organizer

Hanson Wade
Email: info@hansonwade.com


<< Previous article
Introduction to Vali...
Next article > >
Low Endotoxin Recove...